Claris Lifesciences Ltd (533288)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Claris Lifesciences Ltd (533288) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013108
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company offers generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. Its products are offered through various delivery systems such as bags, vials, ampoules, cartridges, glass bottles and plastic bottles. It manufactures and markets products in different markets and therapeutic segments including anesthesia and analgesia, nutrition, blood products, anti-infectives, orphan diseases, hormonal disorders, renal and transplant, oncology and critical care. The company serves institutions, government and private hospitals, aid agencies, and nursing homes. It operates through its manufacturing facility located in Ahmedabad, Gujarat. Claris is headquartered in Ahmedabad, Gujarat, India.

Claris Lifesciences Ltd (533288) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Claris Lifesciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
OrbiMed Advisors Acquires Minority Stake In Claris Lifesciences For US$4 Million 11
Signet Healthcare Partners Acquires 2.2% Stake In Claris Lifesciences For US$4 Million 12
Partnerships 13
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 13
Claris Lifesciences Enters Into Distribution Agreement With Stravencon 14
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 15
Acquisition 17
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 17
Baxter Acquires Claris Injectables for USD625 Million 18
Claris Lifesciences Ltd – Key Competitors 20
Claris Lifesciences Ltd – Key Employees 21
Claris Lifesciences Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 23
Recent Developments 24
Financial Announcements 24
Aug 31, 2016: Claris Lifescience: Q1 FY17 – Results Update 24
Mar 31, 2016: Claris Lifesciences Provides Q4 FY16 Results Update 25
Legal and Regulatory 26
Aug 26, 2016: Claris Update on the PAI US FDA Inspection 26
May 30, 2016: Claris Announces Receipt of EIR from the US FDA 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Claris Lifesciences Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Claris Lifesciences Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
OrbiMed Advisors Acquires Minority Stake In Claris Lifesciences For US$4 Million 11
Signet Healthcare Partners Acquires 2.2% Stake In Claris Lifesciences For US$4 Million 12
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 13
Claris Lifesciences Enters Into Distribution Agreement With Stravencon 14
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 15
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 17
Baxter Acquires Claris Injectables for USD625 Million 18
Claris Lifesciences Ltd, Key Competitors 20
Claris Lifesciences Ltd, Key Employees 21
Claris Lifesciences Ltd, Subsidiaries 22
Claris Lifesciences Ltd, Joint Venture 23

★海外企業調査レポート[Claris Lifesciences Ltd (533288)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magnolia Petroleum Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Marathon Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Marathon Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Marathon Oil Corp (MRO) is independent energy company, which explores, produces and markets liquid hydrocarbons and natural gas. It focuses mainly on unconventional resource plays in the US with op …
  • ConforMIS Inc (CFMS):医療機器:M&Aディール及び事業提携情報
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • PepsiCo Inc:戦略・SWOT・企業財務分析
    PepsiCo Inc - Strategy, SWOT and Corporate Finance Report Summary PepsiCo Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Takeuchi Mfg. Co Ltd:企業の戦略・SWOT・財務分析
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Africa Oil Corp (AOI):石油・ガス:M&Aディール及び事業提携情報
    Summary Africa Oil Corp (AOC) is an oil and gas company that discovers, develops, explores and produces oil and gas assets. The company has oil discoveries in Ekales, Agete, Amosing, Ewoi wells in the Lokichar Basin, and others. It owns and operates various blocks including block 9, block 10A, block …
  • Idacorp Inc (IDA):企業の財務・戦略的SWOT分析
    Summary Idacorp Inc (Idacorp) is an electric utility that distributes, markets, generates and purchases electricity. The utility owns natural gas-fired power plants and in coal-fired generating stations. It offers real estate investments and housing projects. Idacorp owns three coal-fired generating …
  • Arbella Insurance Group:企業の戦略・SWOT・財務情報
    Arbella Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Arbella Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Novadaq Technologies Inc. (NDQ)-医療機器分野:企業M&A・提携分析
    Summary Novadaq Technologies Inc. (Novadaq) is a medical imaging company. It develops, manufactures and markets real-time fluorescence imaging technology products. The company’s SPY Imaging Technology products include SPY Elite open surgical imaging system, PinPoint endoscopic fluorescence imaging s …
  • Sun BioPharma Inc (SNBP):企業の財務・戦略的SWOT分析
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • Ranhill Holdings Berhad (RANHILL):企業の財務・戦略的SWOT分析
    Ranhill Holdings Berhad (RANHILL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tyson Fresh Meats Inc:戦略・SWOT・企業財務分析
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Endava Limited
    Endava Limited - Strategy, SWOT and Corporate Finance Report Summary Endava Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • bluebird bio Inc (BLUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immuno …
  • Rite Aid Corporation:企業のM&A・事業提携・投資動向
    Rite Aid Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rite Aid Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Pepsi-Cola Products Philippines Inc:戦略・SWOT・企業財務分析
    Pepsi-Cola Products Philippines Inc - Strategy, SWOT and Corporate Finance Report Summary Pepsi-Cola Products Philippines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Telenet Group Holding NV (TNET):企業の財務・戦略的SWOT分析
    Telenet Group Holding NV (TNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆